Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 27:372:m4957.
doi: 10.1136/bmj.m4957.

Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study

Greta Hsu  1 , Balázs Kovács  2
Affiliations

Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study

Greta Hsu et al. BMJ. .

Abstract

Objective: To examine county level associations between the prevalence of medical and recreational cannabis stores (referred to as dispensaries) and opioid related mortality rates.

Design: Panel regression methods.

Setting: 812 counties in the United States in the 23 states that allowed legal forms of cannabis dispensaries to operate by the end of 2017.

Participants: The study used US mortality data from the Centers for Disease Control and Prevention combined with US census data and data from Weedmaps.com on storefront dispensary operations. Data were analyzed at the county level by using panel regression methods.

Main outcome measure: The main outcome measures were the log transformed, age adjusted mortality rates associated with all opioid types combined, and with subcategories of prescription opioids, heroin, and synthetic opioids other than methadone. The associations of medical dispensary and recreational dispensary counts with age adjusted mortality rates were also analyzed.

Results: County level dispensary count (natural logarithm) is negatively related to the log transformed, age adjusted mortality rate associated with all opioid types (β=-0.17, 95% confidence interval -0.23 to -0.11). According to this estimate, an increase from one to two storefront dispensaries in a county is associated with an estimated 17% reduction in all opioid related mortality rates. Dispensary count has a particularly strong negative association with deaths caused by synthetic opioids other than methadone (β=-0.21, 95% confidence interval -0.27 to -0.14), with an estimated 21% reduction in mortality rates associated with an increase from one to two dispensaries. Similar associations were found for medical versus recreational storefront dispensary counts on synthetic (non-methadone) opioid related mortality rates.

Conclusions: Higher medical and recreational storefront dispensary counts are associated with reduced opioid related death rates, particularly deaths associated with synthetic opioids such as fentanyl. While the associations documented cannot be assumed to be causal, they suggest a potential association between increased prevalence of medical and recreational cannabis dispensaries and reduced opioid related mortality rates. This study highlights the importance of considering the complex supply side of related drug markets and how this shapes opioid use and misuse.

PubMed Disclaimer

Conflict of interest statement

Competing interests statement: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Figures

Fig 1
Fig 1
County level monthly counts of storefront dispensaries listed on Weedmaps.com in 23 states that allowed legal storefront dispensary operations (plus District of Columbia), averaged over calendar year, 2014-17
Fig 2
Fig 2
Age adjusted mortality rates related to all opioid types at county level for 23 states that allowed legal storefront dispensary operations (plus District of Columbia) for 2015. Mortality rates per 100 000 residents aged 21 years and older
Fig 3
Fig 3
Age adjusted mortality rates related to all opioid types at county level for 23 states that allowed legal storefront dispensary operations (plus District of Columbia) for 2018. Mortality rates per 100 000 residents aged 21 years and older
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. CDC Injury Center. Drug overdose deaths. 2020. https://www.cdc.gov/drugoverdose/data/statedeaths.html.
    1. Bachhuber MA, Saloner B, Cunningham CO, et al. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med 2014;174:1668 10.1001/jamainternmed.2014.4005. - DOI - PMC - PubMed
    1. Livingston MD, Barnett TE, Delcher C, et al. Recreational cannabis legalization and opioid-related deaths in Colorado, 2000-2015. Am J Public Health 2017;107:1827-9. 10.2105/AJPH.2017.304059. - DOI - PMC - PubMed
    1. Chan NW, Burkhardt J, Flyr M. The effects of recreational marijuana legalization and dispensing on opioid mortality. Econ Inq 2020;58:589-606. 10.1111/ecin.12819. - DOI
    1. Powell D, Pacula RL, Jacobson M. Do medical marijuana laws reduce addictions and deaths related to pain killers? J Health Econ 2018;58:29-42. 10.1016/j.jhealeco.2017.12.007. - DOI - PMC - PubMed